Scott R. Vandenberg, MD, PhD - Publications

Pathology University of California, San Diego, La Jolla, CA 

104 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Rajaram S, Roth MA, Malato J, VandenBerg S, Hann B, Atreya CE, Altschuler SJ, Wu LF. A multi-modal data resource for investigating topographic heterogeneity in patient-derived xenograft tumors. Scientific Data. 6: 253. PMID 31672976 DOI: 10.1038/S41597-019-0225-0  0.332
2019 Wang J, Merino DM, Light N, Murphy BL, Wang YD, Guo X, Hodges AP, Chau LQ, Liu KW, Dhall G, Asgharzadeh S, Kiehna EN, Shirey RJ, Janda KD, Taylor MD, ... ... VandenBerg SR, et al. Myc and loss of p53 cooperate to drive formation of choroid plexus carcinoma. Cancer Research. PMID 30885981 DOI: 10.1158/0008-5472.Can-18-2565  0.37
2019 Campbell MJ, Yau C, Bolen J, Vandenberg S, Hoyt C, Brown-Swigart L, Hirst G, Nanda R, Liu M, Asare S, van'tVeer L, Yee D, DeMichele A, Berry D, Esserman L, et al. Abstract CT003: Analysis of immune cell infiltrates as predictors of response to the checkpoint inhibitor pembrolizumab in the neoadjuvant I-SPY 2 TRIAL Cancer Research. 79. DOI: 10.1158/1538-7445.Am2019-Ct003  0.324
2019 Atreya CE, Ruiz-Saenz A, Wang C, Pan B, Dreyer CA, Brunen D, Prahallad A, Spassov D, Steffen DJ, Hann BC, VandenBerg SR, Gutkind S, Moasser MM, Veer LJv', Coppe J. Abstract B023: A reversible SRC-relayed COX2-inflammatory program drives therapeutic resistance in BRAF(V600E) colorectal tumors Molecular Cancer Therapeutics. 18. DOI: 10.1158/1535-7163.Targ-19-B023  0.371
2018 Campbell M, Yau C, Borowsky A, Vandenberg S, Wolf D, Rimm D, Nanda R, Liu M, Brown-Swigart L, Hirst G, Asare S, Veer Lv, Yee D, DeMichele A, Berry D, et al. Abstract PD6-08: Analysis of immune infiltrates (assessed via multiplex fluorescence immunohistochemistry) and immune gene expression signatures as predictors of response to the checkpoint inhibitor pembrolizumab in the neoadjuvant I-SPY 2 trial Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-Pd6-08  0.341
2016 Li J, Taich ZJ, Akers J, Vandenberg S, Chen CC. Abstract 4459: Altered signal transduction in Isocitrate Dehydrogenase (IDH) mutated glioblastomas and implication on precision medicine Cancer Research. 76: 4459-4459. DOI: 10.1158/1538-7445.Am2016-4459  0.327
2015 Jones KA, Gilder AS, Lam MS, Du N, Banki MA, Merati A, Pizzo DP, VandenBerg SR, Gonias SL. Selective coexpression of VEGF receptor 2 in EGFRvIII-positive glioblastoma cells prevents cellular senescence and contributes to their aggressive nature. Neuro-Oncology. PMID 26420897 DOI: 10.1093/Neuonc/Nov243  0.753
2015 Kozono D, Li J, Nitta M, Sampetrean O, Gonda D, Kushwaha DS, Merzon D, Ramakrishnan V, Zhu S, Zhu K, Matsui H, Harismendy O, Hua W, Mao Y, Kwon CH, ... ... VandenBerg SR, et al. Dynamic epigenetic regulation of glioblastoma tumorigenicity through LSD1 modulation of MYC expression. Proceedings of the National Academy of Sciences of the United States of America. 112: E4055-64. PMID 26159421 DOI: 10.1073/Pnas.1501967112  0.325
2015 Wykosky J, Hu J, Gomez GG, Taylor T, Villa GR, Pizzo D, VandenBerg SR, Thorne AH, Chen CC, Mischel PS, Gonias SL, Cavenee WK, Furnari FB. A urokinase receptor-Bim signaling axis emerges during EGFR inhibitor resistance in mutant EGFR glioblastoma. Cancer Research. 75: 394-404. PMID 25432173 DOI: 10.1158/0008-5472.Can-14-2004  0.543
2015 Chen C, Kozono D, Li J, Nitta M, Sampetrean O, Ng K, Gonda D, Kushwaha DS, Merzon D, Ramakrishnan V, Zhu S, Zhu K, Matsui H, Harismendy O, Hua W, ... ... VandenBerg SR, et al. Abstract PR02: Dynamic epigenetic regulation of glioblastoma tumorigenicity through a LSD1-MYC-OLIG2 axis Molecular Cancer Research. 13. DOI: 10.1158/1557-3125.Myc15-Pr02  0.347
2015 Kozono D, Li J, Nitta M, Sampetrean O, Ng K, Gonda D, Kushwaha D, Hiroko M, Harismendy O, Becher O, Kwon C, Ligon KL, Saya H, Carter BS, Pizzo D, ... Vandenberg S, et al. Abstract PR13: Epigenetic regulation of MYC drives dynamic transition between tumor initiating states in glioblastoma Cancer Research. 75. DOI: 10.1158/1538-7445.Chtme14-Pr13  0.387
2015 Li J, Kozono D, Nitta M, Sampetrean O, Gonda D, Kushwaha DS, Merzon D, Ramakrishnan V, Zhu S, Zhu K, Matsui H, Harismendy O, Hua W, Mao Y, Kwon C, ... ... VandenBerg SR, et al. Abstract 979: Dynamic epigenetic regulation of glioblastoma tumorigenicity through LSD1 modulation of MYC expression Cancer Research. 75: 979-979. DOI: 10.1158/1538-7445.Am2015-979  0.386
2015 Li J, Taich Z, Goyal A, Gonda D, Akers J, Adhikari B, Patel K, Vandenberg S, Yan W, Bao Z, Carter B, Wang R, Mao Y, Chen C. EPIG-03EPIGENETIC SUPPRESSION OF EGFR SIGNALING IN G-CIMP + GLIOBLASTOMAS Neuro-Oncology. 17: v86.3-v86. DOI: 10.1093/Neuonc/Nov214.03  0.315
2015 Kozono D, Li J, Sampetrean O, Gonda D, Kushwaha D, Merzon D, Nitta M, Ramakrishnan V, Zhu S, Zhu K, Matsui H, Harismendy O, Hua W, Mao Y, Kwon C, ... ... Vandenberg S, et al. EPIG-02DYNAMIC EPIGENETIC MODULATION OF GLIOBLASTOMA TUMORIGENICITY BY INHIBITION OF LYSINE-SPECIFIC DEMETHYLASE 1 (LSD1) Neuro-Oncology. 17: v86.2-v86. DOI: 10.1093/Neuonc/Nov214.02  0.356
2014 Hu J, Muller KA, Furnari FB, Cavenee WK, VandenBerg SR, Gonias SL. Neutralizing the EGF receptor in glioblastoma cells stimulates cell migration by activating uPAR-initiated cell signaling. Oncogene. PMID 25347738 DOI: 10.1038/onc.2014.336  0.569
2014 Li J, Taich ZJ, Goyal A, Gonda D, Akers J, Adhikari B, Patel K, Vandenberg S, Yan W, Bao Z, Carter BS, Wang R, Mao Y, Jiang T, Chen CC. Epigenetic suppression of EGFR signaling in G-CIMP+ glioblastomas. Oncotarget. 5: 7342-56. PMID 25277177 DOI: 10.18632/Oncotarget.2350  0.316
2014 Farid N, Almeida-Freitas DB, White NS, McDonald CR, Kuperman JM, Almutairi AA, Muller KA, VandenBerg SR, Kesari S, Dale AM. Combining diffusion and perfusion differentiates tumor from bevacizumab-related imaging abnormality (bria). Journal of Neuro-Oncology. 120: 539-46. PMID 25135423 DOI: 10.1007/S11060-014-1583-2  0.328
2014 Hartman LL, Crawford JR, Makale MT, Milburn M, Joshi S, Salazar AM, Hasenauer B, VandenBerg SR, MacDonald TJ, Durden DL. Pediatric phase II trials of poly-ICLC in the management of newly diagnosed and recurrent brain tumors. Journal of Pediatric Hematology/Oncology. 36: 451-7. PMID 24309609 DOI: 10.1097/Mph.0000000000000047  0.315
2014 Wang J, Eberhart C, Ellison D, Vandenberg S, Wechsler-Reya R. PM-22 * GENETICALLY ENGINEERED MOUSE MODELS OF CHOROID PLEXUS TUMORS Neuro-Oncology. 16: v173-v173. DOI: 10.1093/Neuonc/Nou268.22  0.399
2014 Chen C, Kozono D, Li J, Nitta M, Sampetrean O, Gonda D, Kushwaha D, Vandenberg S, Ramakrishnan V, Zhu S, Furnari F, Matsui H, Harismendy O, Cavenee W, Mao Y, et al. CB-04 * EPIGENETIC REGULATION OF GLIOBLASTOMA TUMORIGENICITY: A HYBRID MODEL Neuro-Oncology. 16: v41-v41. DOI: 10.1093/Neuonc/Nou241.4  0.367
2013 Staudt ND, Jo M, Hu J, Bristow JM, Pizzo DP, Gaultier A, VandenBerg SR, Gonias SL. Myeloid cell receptor LRP1/CD91 regulates monocyte recruitment and angiogenesis in tumors. Cancer Research. 73: 3902-12. PMID 23633492 DOI: 10.1158/0008-5472.Can-12-4233  0.606
2013 Read RD, Fenton TR, Gomez GG, Wykosky J, Vandenberg SR, Babic I, Iwanami A, Yang H, Cavenee WK, Mischel PS, Furnari FB, Thomas JB. A kinome-wide RNAi screen in Drosophila Glia reveals that the RIO kinases mediate cell proliferation and survival through TORC2-Akt signaling in glioblastoma. Plos Genetics. 9: e1003253. PMID 23459592 DOI: 10.1371/Journal.Pgen.1003253  0.361
2013 Stoletov K, Strnadel J, Zardouzian E, Momiyama M, Park FD, Kelber JA, Pizzo DP, Hoffman R, VandenBerg SR, Klemke RL. Role of connexins in metastatic breast cancer and melanoma brain colonization. Journal of Cell Science. 126: 904-13. PMID 23321642 DOI: 10.1242/Jcs.112748  0.323
2013 Agarwal M, Nitta R, Dovat S, Li G, Arita H, Narita Y, Fukushima S, Tateishi K, Matsushita Y, Yoshida A, Miyakita Y, Ohno M, Collins VP, Kawahara N, Shibui S, ... ... Vandenberg S, et al. CELL BIOLOGY AND SIGNALING Neuro-Oncology. 15: iii12-iii31. DOI: 10.1093/Neuonc/Not174  0.533
2012 Fenton TR, Nathanson D, Ponte de Albuquerque C, Kuga D, Iwanami A, Dang J, Yang H, Tanaka K, Oba-Shinjo SM, Uno M, Inda MM, Wykosky J, Bachoo RM, James CD, DePinho RA, ... Vandenberg SR, et al. Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240. Proceedings of the National Academy of Sciences of the United States of America. 109: 14164-9. PMID 22891331 DOI: 10.1073/Pnas.1211962109  0.356
2011 Cho J, Pastorino S, Zeng Q, Xu X, Johnson W, Vandenberg S, Verhaak R, Cherniack AD, Watanabe H, Dutt A, Kwon J, Chao YS, Onofrio RC, Chiang D, Yuza Y, et al. Glioblastoma-derived epidermal growth factor receptor carboxyl-terminal deletion mutants are transforming and are sensitive to EGFR-directed therapies. Cancer Research. 71: 7587-96. PMID 22001862 DOI: 10.1158/0008-5472.Can-11-0821  0.301
2011 Sugiarto S, Persson AI, Munoz EG, Waldhuber M, Lamagna C, Andor N, Hanecker P, Ayers-Ringler J, Phillips J, Siu J, Lim DA, Vandenberg S, Stallcup W, Berger MS, Bergers G, et al. Asymmetry-defective oligodendrocyte progenitors are glioma precursors. Cancer Cell. 20: 328-40. PMID 21907924 DOI: 10.1016/J.Ccr.2011.08.011  0.35
2011 Hu J, Jo M, Cavenee WK, Furnari F, VandenBerg SR, Gonias SL. Crosstalk between the urokinase-type plasminogen activator receptor and EGF receptor variant III supports survival and growth of glioblastoma cells. Proceedings of the National Academy of Sciences of the United States of America. 108: 15984-9. PMID 21896743 DOI: 10.1073/Pnas.1113416108  0.62
2011 Khayal IS, Vandenberg SR, Smith KJ, Cloyd CP, Chang SM, Cha S, Nelson SJ, McKnight TR. MRI apparent diffusion coefficient reflects histopathologic subtype, axonal disruption, and tumor fraction in diffuse-type grade II gliomas. Neuro-Oncology. 13: 1192-201. PMID 21865401 DOI: 10.1093/Neuonc/Nor122  0.308
2011 Zheng S, Houseman EA, Morrison Z, Wrensch MR, Patoka JS, Ramos C, Haas-Kogan DA, McBride S, Marsit CJ, Christensen BC, Nelson HH, Stokoe D, Wiemels JL, Chang SM, Prados MD, ... ... Vandenberg SR, et al. DNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expression. Neuro-Oncology. 13: 280-9. PMID 21339190 DOI: 10.1093/Neuonc/Noq190  0.322
2011 Otero JJ, Rowitch D, Vandenberg S. OLIG2 is differentially expressed in pediatric astrocytic and in ependymal neoplasms. Journal of Neuro-Oncology. 104: 423-38. PMID 21193945 DOI: 10.1007/S11060-010-0509-X  0.38
2011 Parsons DW, Li M, Zhang X, Jones S, Leary RJ, Lin JC, Boca SM, Carter H, Samayoa J, Bettegowda C, Gallia GL, Jallo GI, Binder ZA, Nikolsky Y, Hartigan J, ... ... VandenBerg S, et al. The genetic landscape of the childhood cancer medulloblastoma. Science (New York, N.Y.). 331: 435-9. PMID 21163964 DOI: 10.1126/Science.1198056  0.328
2011 Inda MDM, Bonavia R, Vandenberg S, Cavenee W, Furnari F. Abstract 1129: Function of mutant EGFR in maintaining glioblastoma growth and heterogeneity Cancer Research. 71: 1129-1129. DOI: 10.1158/1538-7445.Am2011-1129  0.44
2010 Persson AI, Petritsch C, Swartling FJ, Itsara M, Sim FJ, Auvergne R, Goldenberg DD, Vandenberg SR, Nguyen KN, Yakovenko S, Ayers-Ringler J, Nishiyama A, Stallcup WB, Berger MS, Bergers G, et al. Non-stem cell origin for oligodendroglioma. Cancer Cell. 18: 669-82. PMID 21156288 DOI: 10.1016/J.Ccr.2010.10.033  0.392
2010 Inda MM, Bonavia R, Mukasa A, Narita Y, Sah DW, Vandenberg S, Brennan C, Johns TG, Bachoo R, Hadwiger P, Tan P, Depinho RA, Cavenee W, Furnari F. Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma. Genes & Development. 24: 1731-45. PMID 20713517 DOI: 10.1101/Gad.1890510  0.443
2010 Srinivasan R, Phillips JJ, Vandenberg SR, Polley MY, Bourne G, Au A, Pirzkall A, Cha S, Chang SM, Nelson SJ. Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM. Neuro-Oncology. 12: 1152-61. PMID 20647244 DOI: 10.1093/Neuonc/Noq075  0.339
2010 Swartling FJ, Grimmer MR, Hackett CS, Northcott PA, Fan QW, Goldenberg DD, Lau J, Masic S, Nguyen K, Yakovenko S, Zhe XN, Gilmer HC, Collins R, Nagaoka M, Phillips JJ, ... ... Vandenberg SR, et al. Pleiotropic role for MYCN in medulloblastoma. Genes & Development. 24: 1059-72. PMID 20478998 DOI: 10.1101/Gad.1907510  0.399
2010 Wu AH, Drees JC, Wang H, VandenBerg SR, Lal A, Henner WD, Pillai R. Gene expression profiles help identify the tissue of origin for metastatic brain cancers. Diagnostic Pathology. 5: 26. PMID 20420692 DOI: 10.1186/1746-1596-5-26  0.344
2010 Chen R, Nishimura MC, Bumbaca SM, Kharbanda S, Forrest WF, Kasman IM, Greve JM, Soriano RH, Gilmour LL, Rivers CS, Modrusan Z, Nacu S, Guerrero S, Edgar KA, Wallin JJ, ... ... VandenBerg SR, et al. A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. Cancer Cell. 17: 362-75. PMID 20385361 DOI: 10.1016/J.Ccr.2009.12.049  0.353
2010 Hashizume R, Gupta N, Berger MS, Banerjee A, Prados MD, Ayers-Ringler J, James CD, VandenBerg SR. Morphologic and molecular characterization of ATRT xenografts adapted for orthotopic therapeutic testing. Neuro-Oncology. 12: 366-76. PMID 20308314 DOI: 10.1093/Neuonc/Nop033  0.389
2010 Park I, Larson PE, Zierhut ML, Hu S, Bok R, Ozawa T, Kurhanewicz J, Vigneron DB, Vandenberg SR, James CD, Nelson SJ. Hyperpolarized 13C magnetic resonance metabolic imaging: application to brain tumors. Neuro-Oncology. 12: 133-44. PMID 20150380 DOI: 10.1093/Neuonc/Nop043  0.318
2010 Schiffman JD, Hodgson JG, VandenBerg SR, Flaherty P, Polley MY, Yu M, Fisher PG, Rowitch DH, Ford JM, Berger MS, Ji H, Gutmann DH, James CD. Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas. Cancer Research. 70: 512-9. PMID 20068183 DOI: 10.1158/0008-5472.Can-09-1851  0.344
2010 Inda M, Bonavia R, Sah DW, Vandenberg S, Brennan C, Johns TG, Hadwiger P, Tan P, Cavenee WK, Furnari FB. Abstract 3126: Tumor heterogeneity in glioblastoma is an active process driven by a mutant EGFR-induced paracrine circuit Cancer Research. 70: 3126-3126. DOI: 10.1158/1538-7445.Am10-3126  0.432
2009 Pirzkall A, McGue C, Saraswathy S, Cha S, Liu R, Vandenberg S, Lamborn KR, Berger MS, Chang SM, Nelson SJ. Tumor regrowth between surgery and initiation of adjuvant therapy in patients with newly diagnosed glioblastoma. Neuro-Oncology. 11: 842-52. PMID 19229057 DOI: 10.1215/15228517-2009-005  0.322
2009 Hodgson JG, Yeh RF, Ray A, Wang NJ, Smirnov I, Yu M, Hariono S, Silber J, Feiler HS, Gray JW, Spellman PT, Vandenberg SR, Berger MS, James CD. Comparative analyses of gene copy number and mRNA expression in glioblastoma multiforme tumors and xenografts. Neuro-Oncology. 11: 477-87. PMID 19139420 DOI: 10.1215/15228517-2008-113  0.367
2008 Striedinger K, VandenBerg SR, Baia GS, McDermott MW, Gutmann DH, Lal A. The neurofibromatosis 2 tumor suppressor gene product, merlin, regulates human meningioma cell growth by signaling through YAP. Neoplasia (New York, N.Y.). 10: 1204-12. PMID 18953429 DOI: 10.1593/Neo.08642  0.386
2008 Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M, Vandenberg SR, Ginzinger DG, James CD, Costello JF, Bergers G, Weiss WA, Alvarez-Buylla A, Hodgson JG. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. Bmc Medicine. 6: 14. PMID 18577219 DOI: 10.1186/1741-7015-6-14  0.377
2008 Scheithauer BW, Fuller GN, VandenBerg SR. The 2007 WHO classification of tumors of the nervous system: controversies in surgical neuropathology. Brain Pathology (Zurich, Switzerland). 18: 307-16. PMID 18532929 DOI: 10.1111/J.1750-3639.2008.00179.X  0.346
2008 Du R, Petritsch C, Lu K, Liu P, Haller A, Ganss R, Song H, Vandenberg S, Bergers G. Matrix metalloproteinase-2 regulates vascular patterning and growth affecting tumor cell survival and invasion in GBM. Neuro-Oncology. 10: 254-64. PMID 18359864 DOI: 10.1215/15228517-2008-001  0.333
2008 Du R, Lu KV, Petritsch C, Liu P, Ganss R, Passegué E, Song H, Vandenberg S, Johnson RS, Werb Z, Bergers G. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell. 13: 206-20. PMID 18328425 DOI: 10.1016/J.Ccr.2008.01.034  0.35
2008 Baia GS, Dinca EB, Ozawa T, Kimura ET, McDermott MW, James CD, VandenBerg SR, Lal A. An orthotopic skull base model of malignant meningioma. Brain Pathology (Zurich, Switzerland). 18: 172-9. PMID 18093250 DOI: 10.1111/J.1750-3639.2007.00109.X  0.374
2008 Scheithauer BW, Fuller GN, VandenBerg SR. The 2007 WHO classification of tumors of the nervous system: Controversies in surgical neuropathology (Brain Pathology (2008) 18, (307-316)) Brain Pathology. 18. DOI: 10.1111/J.1750-3639.2008.00219_1.X  0.314
2007 Carvalho LH, Smirnov I, Baia GS, Modrusan Z, Smith JS, Jun P, Costello JF, McDermott MW, Vandenberg SR, Lal A. Molecular signatures define two main classes of meningiomas. Molecular Cancer. 6: 64. PMID 17937814 DOI: 10.1186/1476-4598-6-64  0.32
2007 Lim DA, Cha S, Mayo MC, Chen MH, Keles E, VandenBerg S, Berger MS. Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype. Neuro-Oncology. 9: 424-9. PMID 17622647 DOI: 10.1215/15228517-2007-023  0.361
2007 Wiencke JK, Zheng S, Jelluma N, Tihan T, Vandenberg S, Tamgüney T, Baumber R, Parsons R, Lamborn KR, Berger MS, Wrensch MR, Haas-Kogan DA, Stokoe D. Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma. Neuro-Oncology. 9: 271-9. PMID 17504928 DOI: 10.1215/15228517-2007-003  0.353
2006 Cadieux B, Ching TT, VandenBerg SR, Costello JF. Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation. Cancer Research. 66: 8469-76. PMID 16951158 DOI: 10.1158/0008-5472.Can-06-1547  0.304
2006 Jackson EL, Garcia-Verdugo JM, Gil-Perotin S, Roy M, Quinones-Hinojosa A, VandenBerg S, Alvarez-Buylla A. PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling. Neuron. 51: 187-99. PMID 16846854 DOI: 10.1016/J.Neuron.2006.06.012  0.355
2006 Baia GS, Slocum AL, Hyer JD, Misra A, Sehati N, VandenBerg SR, Feuerstein BG, Deen DF, McDermott MW, Lal A. A genetic strategy to overcome the senescence of primary meningioma cell cultures. Journal of Neuro-Oncology. 78: 113-21. PMID 16554968 DOI: 10.1007/S11060-005-9076-Y  0.357
2005 Entin-Meer M, Rephaeli A, Yang X, Nudelman A, VandenBerg SR, Haas-Kogan DA. Butyric acid prodrugs are histone deacetylase inhibitors that show antineoplastic activity and radiosensitizing capacity in the treatment of malignant gliomas. Molecular Cancer Therapeutics. 4: 1952-61. PMID 16373710 DOI: 10.1158/1535-7163.Mct-05-0087  0.32
2005 Ozawa T, Britz GW, Kinder DH, Spence AM, VandenBerg S, Lamborn KR, Deen DF, Berger MS. Bromophenol blue staining of tumors in a rat glioma model. Neurosurgery. 57: 1041-7; discussion 1. PMID 16284574 DOI: 10.1227/01.Neu.0000180036.42193.F6  0.336
2005 Salasznyk RM, Westcott AM, Klees RF, Ward DF, Xiang Z, Vandenberg S, Bennett K, Plopper GE. Comparing the protein expression profiles of human mesenchymal stem cells and human osteoblasts using gene ontologies. Stem Cells and Development. 14: 354-66. PMID 16137224 DOI: 10.1089/Scd.2005.14.354  0.3
2004 Rola R, Raber J, Rizk A, Otsuka S, VandenBerg SR, Morhardt DR, Fike JR. Radiation-induced impairment of hippocampal neurogenesis is associated with cognitive deficits in young mice. Experimental Neurology. 188: 316-30. PMID 15246832 DOI: 10.1016/J.Expneurol.2004.05.005  0.301
2002 Giannini C, Scheithauer BW, Lopes MB, Hirose T, Kros JM, VandenBerg SR. Immunophenotype of pleomorphic xanthoastrocytoma. The American Journal of Surgical Pathology. 26: 479-85. PMID 11914626 DOI: 10.1097/00000478-200204000-00010  0.304
2002 Hussaini IM, Carpenter JE, Redpath GT, Sando JJ, Shaffrey ME, Vandenberg SR. Protein kinase C-eta regulates resistance to UV- and gamma-irradiation-induced apoptosis in glioblastoma cells by preventing caspase-9 activation. Neuro-Oncology. 4: 9-21. PMID 11772428 DOI: 10.1093/Neuonc/4.1.9  0.358
2001 Mandell JW, Gocan NC, Vandenberg SR. Mechanical trauma induces rapid astroglial activation of ERK/MAP kinase: Evidence for a paracrine signal. Glia. 34: 283-95. PMID 11360301 DOI: 10.1002/Glia.1062  0.309
2000 Hussaini IM, Karns LR, Vinton G, Carpenter JE, Redpath GT, Sando JJ, VandenBerg SR. Phorbol 12-myristate 13-acetate induces protein kinase ceta-specific proliferative response in astrocytic tumor cells. The Journal of Biological Chemistry. 275: 22348-54. PMID 10806212 DOI: 10.1074/Jbc.M003203200  0.375
1999 Hirano H, Lopes MB, Laws ER, Asakura T, Goto M, Carpenter JE, Karns LR, VandenBerg SR. Insulin-like growth factor-1 content and pattern of expression correlates with histopathologic grade in diffusely infiltrating astrocytomas. Neuro-Oncology. 1: 109-19. PMID 11550306 DOI: 10.1093/Neuonc/1.2.109  0.383
1999 Mandell JW, VandenBerg SR. ERK/MAP kinase is chronically activated in human reactive astrocytes. Neuroreport. 10: 3567-72. PMID 10619645 DOI: 10.1097/00001756-199911260-00019  0.304
1999 Hussaini IM, Brown MD, Weaver AM, Carpenter J, Karns LR, Vandenberg SR, Gonias SL. Stable antisense RNA expression neutralizes the activity of low-density lipoprotein receptor-related protein and promotes urokinase accumulation in the medium of an astrocytic tumor cell line. Antisense & Nucleic Acid Drug Development. 9: 183-90. PMID 10355824 DOI: 10.1089/Oli.1.1999.9.183  0.619
1999 Hussaini IM, Brown MD, Karns LR, Carpenter J, Redpath GT, Gonias SL, Vandenberg SR. Epidermal growth factor differentially regulates low density lipoprotein receptor-related protein gene expression in neoplastic and fetal human astrocytes. Glia. 25: 71-84. PMID 9888299 DOI: 10.1002/(Sici)1098-1136(19990101)25:1<71::Aid-Glia7>3.0.Co;2-0  0.621
1998 Mandell JW, Hussaini IM, Zecevic M, Weber MJ, VandenBerg SR. In situ visualization of intratumor growth factor signaling: immunohistochemical localization of activated ERK/MAP kinase in glial neoplasms. The American Journal of Pathology. 153: 1411-23. PMID 9811332 DOI: 10.1016/S0002-9440(10)65728-8  0.379
1997 Decaestecker C, Lopes BS, Gordower L, Camby I, Cras P, Martin JJ, Kiss R, VandenBerg SR, Salmon I. Quantitative chromatin pattern description in Feulgen-stained nuclei as a diagnostic tool to characterize the oligodendroglial and astroglial components in mixed oligo-astrocytomas. Journal of Neuropathology and Experimental Neurology. 56: 391-402. PMID 9100670 DOI: 10.1097/00005072-199704000-00008  0.327
1997 Brown MD, Banker GA, Hussaini IM, Gonias SL, VandenBerg SR. Low density lipoprotein receptor-related protein is expressed early and becomes restricted to a somatodendritic domain during neuronal differentiation in culture. Brain Research. 747: 313-7. PMID 9046007 DOI: 10.1016/S0006-8993(96)01321-2  0.538
1996 Lopes MB, Altermatt HJ, Scheithauer BW, Shepherd CW, VandenBerg SR. Immunohistochemical characterization of subependymal giant cell astrocytomas. Acta Neuropathologica. 91: 368-75. PMID 8928613 DOI: 10.1007/S004010050438  0.396
1996 Shaffrey ME, Lanzino G, Lopes MB, Hessler RB, Kassell NF, VandenBerg SR. Maturation of intracranial immature teratomas. Report of two cases. Journal of Neurosurgery. 85: 672-6. PMID 8814173 DOI: 10.3171/Jns.1996.85.4.0672  0.343
1996 Hussaini IM, LaMarre J, Lysiak JJ, Karns LR, VandenBerg SR, Gonias SL. Transcriptional regulation of LDL receptor-related protein by IFN-gamma and the antagonistic activity of TGF-beta(1) in the RAW 264.7 macrophage-like cell line. Journal of Leukocyte Biology. 59: 733-9. PMID 8656060 DOI: 10.1002/Jlb.59.5.733  0.536
1996 Hussaini IM, Lopes MB, Musante DB, Karns LR, VandenBerg SR. EXPRESSION OF IGF-1 AND IGF-1R IN REACTIVE ASTROCYTES AND ASTROCYTIC TUMORS Journal of Neuropathology and Experimental Neurology. 55: 606. DOI: 10.1097/00005072-199605000-00020  0.305
1995 Hirose T, Scheithauer BW, Lopes MB, Gerber HA, Altermatt HJ, Hukee MJ, VandenBerg SR, Charlesworth JC. Tuber and subependymal giant cell astrocytoma associated with tuberous sclerosis: an immunohistochemical, ultrastructural, and immunoelectron and microscopic study. Acta Neuropathologica. 90: 387-99. PMID 8546029 DOI: 10.1007/Bf00315012  0.359
1994 Lopes MB, Bogaev CA, Gonias SL, VandenBerg SR. Expression of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein is increased in reactive and neoplastic glial cells. Febs Letters. 338: 301-5. PMID 8307199 DOI: 10.1016/0014-5793(94)80288-2  0.551
1994 Turner JS, Redpath GT, Humphries JE, Gonias SL, Vandenberg SR. Plasmin modulates the thrombin-evoked calcium response in C6 glioma cells. The Biochemical Journal. 297: 175-9. PMID 8280096 DOI: 10.1042/Bj2970175  0.543
1994 Hirose T, Scheithauer BW, Lopes MB, VandenBerg SR. Dysembryoplastic neuroeptihelial tumor (DNT): an immunohistochemical and ultrastructural study. Journal of Neuropathology and Experimental Neurology. 53: 184-95. PMID 8120540 DOI: 10.1097/00005072-199403000-00010  0.358
1993 Lopes MB, Gonzalez-Fernandez F, Scheithauer BW, VandenBerg SR. Differential expression of retinal proteins in a pineal parenchymal tumor. Journal of Neuropathology and Experimental Neurology. 52: 516-24. PMID 8360704 DOI: 10.1097/00005072-199309000-00010  0.353
1993 Altermatt HJ, Lopes MB, Scheithauer BW, VandenBerg SR. THE IMMUNOCHEMISTRY OF SUBEPENDYMAL GIANT CELL ASTROCYTOMA (SEGA) IN TUBEROUS SCLEROSIS (TS) Journal of Neuropathology and Experimental Neurology. 52: 326. DOI: 10.1097/00005072-199305000-00265  0.311
1992 Hessler RB, Lopes MB, Frankfurter A, Reidy J, VandenBerg SR. Cytoskeletal immunohistochemistry of central neurocytomas. The American Journal of Surgical Pathology. 16: 1031-8. PMID 1471723 DOI: 10.1097/00000478-199211000-00001  0.361
1992 VandenBerg SR. Current diagnostic concepts of astrocytic tumors. Journal of Neuropathology and Experimental Neurology. 51: 644-57. PMID 1362439 DOI: 10.1097/00005072-199211000-00008  0.312
1991 Humphries J, Hall S, VandenBerg S, Gonias S. Streptokinase-plasmin complex binds to plasminogen receptors on rat hepatocytes and human endothelium Fibrinolysis. 5: 171-176. DOI: 10.1016/0268-9499(91)90019-Z  0.543
1990 Hall SW, VandenBerg SR, Gonias SL. Plasminogen carbohydrate side chains in receptor binding and enzyme activation: a study of C6 glioma cells and primary cultures of rat hepatocytes. Journal of Cellular Biochemistry. 43: 213-27. PMID 1696276 DOI: 10.1002/Jcb.240430303  0.566
1990 Keohane ME, Hall SW, VandenBerg SR, Gonias SL. Secretion of alpha 2-macroglobulin, alpha 2-antiplasmin, and plasminogen activator inhibitor-1 by glioblastoma multiforme in primary organ culture. Journal of Neurosurgery. 73: 234-41. PMID 1694891 DOI: 10.3171/Jns.1990.73.2.0234  0.528
1989 VandenBerg SR, Gonias SL. Covalent complexes of albumin with serotonin, ketanserin and lysergic acid antagonize the activity of serotonin in human platelets. Life Sciences. 44: 1777-85. PMID 2733551 DOI: 10.1016/0024-3205(89)90565-1  0.49
1989 VandenBerg SR, Britt SG, Redpath GT, Gonias SL. 5-Hydroxytryptamine2 (5-HT2) structure-function relationships of the nitro and amino phenylpiperazines on intact human platelets. Biochemical Pharmacology. 38: 4237-44. PMID 2597195 DOI: 10.1016/0006-2952(89)90521-2  0.516
1989 Klein P, Haley EC, Wooten GF, VandenBerg SR. Focal cerebral infarctions associated with perivascular tumor infiltrates in carcinomatous leptomeningeal metastases. Archives of Neurology. 46: 1149-52. PMID 2552969 DOI: 10.1001/Archneur.1989.00520460145030  0.323
1989 Hall SW, VandenBerg SR, Gonias SL. Expression of plasminogen receptors on C6 glioma cells. Brain Research. 495: 373-6. PMID 2548675 DOI: 10.1016/0006-8993(89)90231-X  0.571
1989 Gonias SL, Braud LL, Geary WA, VandenBerg SR. Plasminogen binding to rat hepatocytes in primary culture and to thin slices of rat liver. Blood. 74: 729-36. PMID 2546631 DOI: 10.1182/Blood.V74.2.729.Bloodjournal742729  0.529
1987 VandenBerg SR, May EE, Rubinstein LJ, Herman MM, Perentes E, Vinores SA, Collins VP, Park TS. Desmoplastic supratentorial neuroepithelial tumors of infancy with divergent differentiation potential ("desmoplastic infantile gangliogliomas"). Report on 11 cases of a distinctive embryonal tumor with favorable prognosis. Journal of Neurosurgery. 66: 58-71. PMID 3097276 DOI: 10.3171/Jns.1987.66.1.0058  0.379
1987 Vandenberg SR, Herman MM, Rubinstein LJ. Embryonal central neuroepithelial tumors: current concepts and future challenges. Cancer Metastasis Reviews. 5: 343-65. PMID 2882864 DOI: 10.1007/Bf00055377  0.386
1984 Weaver D, Vandenberg S, Park TS, Jane JA. Selective peripancreatic sarcoma metastases from primary gliosarcoma. Case report. Journal of Neurosurgery. 61: 599-601. PMID 6747700 DOI: 10.3171/Jns.1984.61.3.0599  0.323
1982 Ramsay PB, VandenBerg SR, Eng LF, Herman MM, Rubinstein LJ. Immunologic recognition of cell surface antigens in normal mouse neural tissues and in neuroepithelial cells of the OTT-6050 mouse teratoma. A radiometric, gel electrophoretic and morphologic (immunofluorescence and immunoperoxidase) study. Acta Neuropathologica. 56: 214-24. PMID 7200313 DOI: 10.1007/Bf00690638  0.318
1981 DeArmond SJ, VandenBerg SR, Herman MM. Neural differentiation in the OTT-6050 mouse teratoma: effects of intracerebral environment on the neural differentiation of embryoid bodies. Virchows Archiv. a, Pathological Anatomy and Histology. 393: 39-52. PMID 7347442 DOI: 10.1007/Bf00430869  0.345
1981 VandenBerg SR, Hess JR, Herman MM, DeArmond SJ, Halks-Miller M, Rubinstein LJ. Neural differentiation in the OTT-6050 mouse teratoma. Production of a tumor fraction showing melanogenesis in neuroepithelial cells after centrifugal elutriation. Virchows Archiv. a, Pathological Anatomy and Histology. 392: 295-308. PMID 7269229 DOI: 10.1007/Bf02155667  0.36
1981 VandenBerg SR, Chatel M, Griffiths OM, DeArmond SJ, Pappas C, Herman MM. Neural differentiation in the OTT-6050 mouse teratoma. Production of a tumor fraction restricted to stem cells and neural cells after centrifugal elutriation. Virchows Archiv. a, Pathological Anatomy and Histology. 392: 281-94. PMID 7269228 DOI: 10.1007/Bf02155666  0.37
1981 Erdelyi E, VandenBerg SR, Raese J, Barchas JD, Rubinstein LJ, Herman MM. Neural differentiation in the OTT-6050 mouse teratoma: enzymatic and immunofluorescence characterization of a tumor fraction showing melanogenesis in neuroepithelial cells. Virchows Archiv. a, Pathological Anatomy and Histology. 393: 27-37. PMID 6126948 DOI: 10.1007/Bf00430868  0.375
1976 Wada HG, VandenBerg SR, Sussman HH, Grove WE, Herman MM. Characterization of two different alkaline phosphatases in mouse teratoma: partial purification, electrophoretic, and histochemical studies. Cell. 9: 37-44. PMID 987856 DOI: 10.1016/0092-8674(76)90050-7  0.308
1976 Orenberg EK, Vandenberg SR, Barchas JD, Herman MM. Neurochemical studies in a mouse teratoma with neuroepithelial differentiation. Presence of cyclic AMP, serotonin and enzymes of the serotonergic, adrenergic and cholinergic systems. Brain Research. 101: 273-81. PMID 1140 DOI: 10.1016/0006-8993(76)90268-7  0.309
1975 Spence AM, Vandenberg SR, Herman MM. Intracisternal A-particles in transplantable murine teratomas. Beitrã¤Ge Zur Pathologie. 155: 428-34. PMID 1180813 DOI: 10.1016/S0005-8165(75)80105-3  0.301
Show low-probability matches.